Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.79 USD | -1.10% |
|
-4.74% | -9.53% |
05-14 | Cantor Fitzgerald Adjusts Price Target on Exagen to $7 From $5, Maintains Overweight Rating | MT |
05-13 | Exagen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.53% | 31.45M | |
+16.83% | 82.53B | |
-27.08% | 73B | |
-1.13% | 26.4B | |
-11.12% | 17.12B | |
+0.57% | 17.09B | |
-0.57% | 15.23B | |
+73.77% | 13.24B | |
+77.01% | 13.02B | |
-25.09% | 12.82B |
- Stock Market
- Equities
- XGN Stock
- News Exagen Inc.
- Exagen Inc. Provides Earnings Guidance for the Fiscal Year 2021